Goldman Names 23 Defensive Stocks for Investors Worried About the AI Trade
Goldman Sachs is steering investors worried about the artificial intelligence (AI) trade toward health care and consumer staples stocks. Goldmans call comes less than a week after RBC Capital Markets cut tech to market weight. On October 14, RBC recommended health care in its place. Sponsored Sponsored Rising Rates Put the AI Earnings Engine Under Pressure Goldmans case starts with interest rates. Analysts led by Ben Snider said months of rate pressure have raised concerns over the cost of capital. In turn, the stock market has lowered its growth expectations. “A sharp reduction in investor positioning has amplified equity market moves,” the analysts said. Goldmans Cyclicals vs. Defensives pair fell 6% in the past 2 weeks, meaning cyclical stocks underperformed defensive ones. That matters for index investors, since Goldman estimates AI capital spending drives about half of S&P 500 earnings growth. The bank expects that share to shrink as spending growth slows. It also sees S&P 500 earnings growth cooling from around 29% in 2026 to 18% in 2027. RBC reached health care through a different signal. Lori Calvasina, its head of US equity strategy, said the pace of upward earnings revisions remains strong for tech overall. However, that pace has started to slow somewhat for semiconductor and









